Lilly (Eli) & Co (NYSE:LLY) on 06/19/2019 declared a dividend of $ 0.6450 per share payable on September 10, 2019 to shareholders of record as of August 15, 2019.

Lilly (Eli) & Co (NYSE:LLY) has paid dividends since 1885, has a current dividend yield of 2.2503268719% and has increased its dividends for 4 successive years.

Lilly (Eli) & Co's market cap is $ 111,305,774,150 and has a PE ratio of 18.26. The stock price closed yesterday at $ 114.65 and has a 52 week low/high of $ 84.64 and $ 132.13.

Eli Lilly and Company is engaged in discovering, developing, manufacturing, and marketing products in two business segments: human pharmaceutical products; and animal health products. Co.'s human pharmaceutical products include: cardiovascular, endocrinology, immunology, neuroscience and oncology products. Co.'s animal health products are comprised of products for animals, among others, which include Clynav™, a vaccine to control pancreas disease in salmon; Coban®, Maxiban®, and Monteban®, anticoccidial agents for use in poultry; as well as products for companion animals, which include Comfortis®, a chewable tablet that kills fleas and prevents flea infestations on dogs.

For more information on Lilly (Eli) & Co click here.